Literature DB >> 31313673

Cullin-Ring ubiquitin ligases in kidney health and disease.

Ryan J Cornelius1, Mohammed Z Ferdaus, Jonathan W Nelson, James A McCormick.   

Abstract

PURPOSE OF REVIEW: Members of the Cullin family act as scaffolds in E3 ubiquitin ligases and play a central role in mediating protein degradation. Interactions with many different substrate-binding adaptors permit Cullin-containing E3 ligases to participate in diverse cellular functions. In the kidney, one well established target of Cullin-mediated degradation is the transcription factor Nrf2, a key player in responses to oxidative stress. The goal of this review is to discuss more recent findings revealing broader roles for Cullins in the kidney. RECENT
FINDINGS: Cullin 3 acts as the scaffold in the E3 ligase regulating Nrf2 abundance, but was more recently shown to be mutated in the disease familial hyperkalemic hypertension. Studies seeking to elucidate the molecular mechanisms by which Cullin 3 mutations lead to dysregulation of renal sodium transport will be discussed. Disruption of Cullin 3 in mice unexpectedly causes polyuria and fibrotic injury suggesting it has additional roles in the kidney. We will also review recent transcriptomic data suggesting that other Cullins are also likely to play important roles in renal function.
SUMMARY: Cullins form a large and diverse family of E3 ubiquitin ligases that are likely to have many important functions in the kidney.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31313673      PMCID: PMC6686897          DOI: 10.1097/MNH.0000000000000527

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  62 in total

1.  The COP9 signalosome regulates Skp2 levels and proliferation of human cells.

Authors:  Simona Denti; Maria Elena Fernandez-Sanchez; Lars Rogge; Elisabetta Bianchi
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

2.  Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.

Authors:  Nosratola D Vaziri; Shuman Liu; Seyed H Farzaneh; Sohrab Nazertehrani; Mahyar Khazaeli; Ying-Yong Zhao
Journal:  Free Radic Biol Med       Date:  2015-04-28       Impact factor: 7.376

3.  Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome.

Authors:  Merav D Shmueli; Limor Levy-Kanfo; Esraa Haj; Alan R Schoenfeld; Ehud Gazit; Daniel Segal
Journal:  Oncogene       Date:  2018-09-07       Impact factor: 9.867

4.  Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

Authors:  Glenn M Chertow; Gerald B Appel; Geoffrey A Block; Melanie P Chin; Daniel W Coyne; Angie Goldsberry; Kamyar Kalantar-Zadeh; Colin J Meyer; Mark E Molitch; Pablo E Pergola; Philip Raskin; Arnold L Silva; Bruce Spinowitz; Stuart M Sprague; Peter Rossing
Journal:  J Diabetes Complications       Date:  2018-09-13       Impact factor: 2.852

5.  Human hypertension caused by mutations in WNK kinases.

Authors:  F H Wilson; S Disse-Nicodème; K A Choate; K Ishikawa; C Nelson-Williams; I Desitter; M Gunel; D V Milford; G W Lipkin; J M Achard; M P Feely; B Dussol; Y Berland; R J Unwin; H Mayan; D B Simon; Z Farfel; X Jeunemaitre; R P Lifton
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 6.  New Insights Into the Mechanism of COP9 Signalosome-Cullin-RING Ubiquitin-Ligase Pathway Deregulation in Urological Cancers.

Authors:  Linda Gummlich; Thilo Kähne; Michael Naumann; Ergin Kilic; Klaus Jung; Wolfgang Dubiel
Journal:  Int Rev Cell Mol Biol       Date:  2016-02-16       Impact factor: 6.813

7.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.

Authors:  Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

8.  A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.

Authors:  Shailender Bhatia; Anna C Pavlick; Peter Boasberg; John A Thompson; George Mulligan; Michael D Pickard; Hélène Faessel; Bruce J Dezube; Omid Hamid
Journal:  Invest New Drugs       Date:  2016-04-08       Impact factor: 3.850

9.  ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.

Authors:  Meena Murthy; Thimo Kurz; Kevin M O'Shaughnessy
Journal:  Physiol Rep       Date:  2016-07

10.  KLHL5 knockdown increases cellular sensitivity to anticancer drugs.

Authors:  Robert J Schleifer; Shuchun Li; Wyatt Nechtman; Eric Miller; Shan Bai; Ashok Sharma; Jin-Xiong She
Journal:  Oncotarget       Date:  2018-12-21
View more
  2 in total

Review 1.  Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.

Authors:  Ryan J Cornelius; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

2.  COP9 signalosome deletion promotes renal injury and distal convoluted tubule remodeling.

Authors:  Ryan J Cornelius; Jonathan W Nelson; Xiao-Tong Su; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.